LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.80 Cr | ₹8.52 Cr | ₹6.59 Cr | ₹3.32 Cr | ₹3.16 Cr |
What is the latest Contingent Liabilities ratio of LACTOSE (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹7.80 Cr |
| Mar2024 | ₹8.52 Cr |
| Mar2023 | ₹6.59 Cr |
| Mar2022 | ₹3.32 Cr |
| Mar2021 | ₹3.16 Cr |
How is Contingent Liabilities of LACTOSE (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.80 Cr | -8.52 | |
| Mar2024 | ₹8.52 Cr | 29.32 | |
| Mar2023 | ₹6.59 Cr | 98.58 | |
| Mar2022 | ₹3.32 Cr | 4.93 | |
| Mar2021 | ₹3.16 Cr | - | |
Compare Contingent Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹127.2 Cr | 0.8% | -5.5% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 0.8% |
-5.5% |
6.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses